Michael Poulsen

7.9k total citations · 1 hit paper
114 papers, 4.9k citations indexed

About

Michael Poulsen is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Poulsen has authored 114 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 36 papers in Otorhinolaryngology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Poulsen's work include Head and Neck Cancer Studies (36 papers), Advanced Radiotherapy Techniques (20 papers) and Polyomavirus and related diseases (18 papers). Michael Poulsen is often cited by papers focused on Head and Neck Cancer Studies (36 papers), Advanced Radiotherapy Techniques (20 papers) and Polyomavirus and related diseases (18 papers). Michael Poulsen collaborates with scholars based in Australia, New Zealand and United Kingdom. Michael Poulsen's co-authors include Lee Tripcony, Jacqui Keller, James W. Denham, Sandro Porceddu, Michael Veness, Jennifer A. Harvey, Peter C. O’Brien, Danny Rischin, Nigel Spry and Matthew Foote and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Michael Poulsen

111 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

2006 752 citations Michael Poulsen et al. profile →

Peers

Countries citing papers authored by Michael Poulsen

Since Specialization

Citations

This map shows the geographic impact of Michael Poulsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Poulsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Poulsen more than expected).

Fields of papers citing papers by Michael Poulsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Poulsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Poulsen. The network helps show where Michael Poulsen may publish in the future.

Co-authorship network of co-authors of Michael Poulsen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Poulsen. A scholar is included among the top collaborators of Michael Poulsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Poulsen. Michael Poulsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evidence-based Peer Review for Radiation Therapy – Updated Review of the Literature with a Focus on Tumour Subsite and Treatment Modality 2017 ·Clinical Oncology ·Michael Huo, Peter Gorayski, Michael Poulsen, (unknown), Mark B. Pinkham	29
2	The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05) 2013 ·Radiotherapy and Oncology ·David Ball, Richard Fisher, Bryan Burmeister, Michael Poulsen, Peter Graham, Michael Penniment, Shalini Vinod, Hedley Krawitz, David Joseph, Greg Wheeler, Bev McClure	53
3	Cutaneous Carcinoma of the Head and Neck with Clinical Features of Perineural Infiltration Treated with Radiotherapy 2013 ·Clinical Oncology ·Charles Lin, Lee Tripcony, Jacqui Keller, Michael Poulsen, Graeme Dickie	32
4	The Impact of Preradiation Residual Disease Volume on Time to Locoregional Failure in Cutaneous Merkel Cell Carcinoma—A TROG Substudy 2013 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), George Hruby, Chris Wratten, Jacqui Keller, Lee Tripcony, Graeme Dickie, Danny Rischin, Michael Poulsen	19
5	Factors associated with subjective well‐being in cancer workers in Queensland 2012 ·Journal of Medical Imaging and Radiation Oncology ·Michael Poulsen, Anne A. Poulsen, Asaduzzaman Khan, (unknown), Shanchita R. Khan	14
6	The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers 2011 ·British Journal of Dermatology ·Jonathan Ramsay, Andreas Suhrbier, James Aylward, Steven M. Ogbourne, Sarah‐Jane Cozzi, Michael Poulsen, Kathryn Baumann, (unknown), (unknown), Peter G. Parsons	82
7	Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy 2011 ·Head & Neck ·Sandro Porceddu, David Pryor, Elizabeth Burmeister, Bryan Burmeister, Michael Poulsen, Matthew Foote, Benedict Panizza, Scott Coman, (unknown), William B. Coman	131
8	ORIGINAL ARTICLE: Comparison of a Commonwealth‐initiated regional radiation oncology facility in Toowoomba with a Queensland Health facility 2010 ·Journal of Medical Imaging and Radiation Oncology ·Michael Poulsen, Mark R. Middleton, Shaun McQuitty, (unknown), (unknown), Jennifer Martin, (unknown), Winnie Wong, Robert B. Fairweather, Euan Walpole	0
9	The complex relationship of lung tumor volume to survival in patients with non-small cell lung cancer (NSCLC) treated by definitive radiotherapy (RT): (Trans Tasman Radiation Oncology Group Study 9905) 2009 ·Journal of Thoracic Oncology ·David Ball, Richard A. Fisher, Bryan Burmeister, Michael Poulsen, Peter Graham, Michael Penniment, Shalini Vinod, Hedley Krawitz, David Joseph, Greg Wheeler, Bev McClure	1
10	Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial” 2007 ·Radiotherapy and Oncology ·Sandro Porceddu, (unknown), Bryan Burmeister, Mark Jones, Brigid E Hickey, (unknown), (unknown), (unknown), Michael Poulsen, Tanya Holt	105
11	Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck 2006 ·Head & Neck ·Tom Vauterin, Michael Veness, Gary J. Morgan, Michael Poulsen, Christopher J. O’Brien	103
12	Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 Database 2006 ·Journal of Thoracic Oncology ·David Ball, Richard Fisher, Bryan Burmeister, Peter Graham, David Joseph, Michael Penniment, Hedley Krawitz, Greg Wheeler, Michael Poulsen, Shalini Vinod, Bev McClure	24
13	Merkel-cell carcinoma of the skin 2004 ·The Lancet Oncology ·Michael Poulsen	140
14	A prospective trial of short‐fractionation radiotherapy for the palliation of liver metastases 2003 ·Australasian Radiology ·Sean Bydder, Nigel Spry, David Christie, Daphne Roos, B. Burmeister, Hedley Krawitz, S Davis, (unknown), Michael Poulsen, Martin Berry	36
15	Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer 2003 ·Radiotherapy and Oncology ·David S. Lamb, James W. Denham, Hedy Mameghan, David Joseph, Sandra Turner, John Matthews, Ian M. Franklin, Chris Atkinson, J. B. North, Michael Poulsen, (unknown), (unknown), (unknown), David Christie, Nigel Spry, Keen Hun Tai, Chris Wynne, Gillian Duchesne	30
16	How do waiting times affect radiation dose fractionation schedules? 2000 ·Australasian Radiology ·(unknown), Michael Poulsen	10
17	Development of a CCD array imaging system for measurement of dose distributions in doped agarose gels 1997 ·Medical Physics ·(unknown), (unknown), T. van Doorn, (unknown), Michael Poulsen	12
18	Nodal Recurrence in Primary Malignant Epithelial Turnours of the Parotid Gland 1991 ·Australasian Radiology ·Michael Poulsen, Lee Tripcony, (unknown)	9
19	Arteriovenous malformations—A summary of 6 cases treated with radiation therapy 1987 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Poulsen	25
20	Prognostic variables in endometrial carcinoma 1987 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Poulsen, (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact